The Net Chance of a Longer Survival as a Patient-Oriented Measure of Treatment Benefit in Randomized Clinical Trials - Université Claude Bernard Lyon 1 Accéder directement au contenu
Article Dans Une Revue JAMA oncology Année : 2016

The Net Chance of a Longer Survival as a Patient-Oriented Measure of Treatment Benefit in Randomized Clinical Trials

Dates et versions

hal-02053619 , version 1 (01-03-2019)

Identifiants

Citer

Julien Péron, Pascal Roy, B. Ozenne, L. Roche, M. Buyse. The Net Chance of a Longer Survival as a Patient-Oriented Measure of Treatment Benefit in Randomized Clinical Trials. JAMA oncology, 2016, 2, pp.901-905. ⟨10.1001/jamaoncol.2015.6359⟩. ⟨hal-02053619⟩
19 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More